oxoglaucine has been researched along with Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azamov, B; Hur, J; Lee, C; Lee, KM; Muradillaeva, S; Shim, WS; Song, P | 1 |
1 other study(ies) available for oxoglaucine and Fibrosis
| Article | Year |
|---|---|
Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation.
Topics: Fibrosis; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Phosphorylation; Reactive Oxygen Species; Smad Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2023 |